Recent Industry Developments FDA Approval of Oral Wegovy and Orforglipron (Regulatory): On December 22, 2025, the FDA approved the first oral GLP-1 specifically for chronic weight management (the Wegovy pill), which launched in January 2026
Whole-genome sequence analysis revealed novel subjective cognitive decline-associated genes in 10,763 Chinese
Presently, we have a 24 page report that is personalized for the patient wanting a more comprehensive genomic review
Higher insulin levels can lead to high cholesterol, hypertension, vascular complications, and hardened arteries
The above studies systematically reveal a close connection between ferroptosis and various metabolic pathways, providing a theoretical basis for further understanding its pathological mechanisms in colitis and other related diseases
Post-Workout Once your training or competition ends your body and muscles enter recovery mode